Report #2835385

Received Apr 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 66 yrs
State: ME
Recovered: Not recovered
Vaccinated: Apr 4, 2025
Onset: Apr 7, 2025
Days to onset: 3
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	IM

Symptoms (1)

Injection site erythema

Symptom narrative

redness to skin; This non-serious case was reported by a consumer via call center representative and described the occurrence of skin red in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 04-APR-2025 11:30, the patient received the 1st dose of Shingrix (intramuscular, unknown deltoid). On 07-APR-2025, 3 days after receiving Shingrix, the patient experienced skin red (Verbatim: redness to skin). The outcome of the skin red was not resolved. It was unknown if the reporter considered the skin red to be related to Shingrix. It was unknown if the company considered the skin red to be related to Shingrix. Additional Information: GSK Receipt Date: 07-APR-2025 The case was self reported by patient. The patient received Shingrix vaccine and experienced redness to skin. The patient developed a 4 inch by 2 inch area of redness on his bicep about 5 inches from the injection site. Nothing else was reported.